Oncology CAR-TCR 2023 – Mindy Miller As more cell therapies are approved and the category emerges, there’s also an increased need for the technology that enables cell therapy development.
News Vogenx surpasses expectations with $81M IPO With $81.3 million raised, Vogenx is the latest in a staggering summer of biotech IPOs. But the queue past this point looks thin.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
